{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:34:22Z","timestamp":1793525662153,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10787-026-02284-5","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:17:54Z","timestamp":1781493474000},"page":"4463-4481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis"],"prefix":"10.1007","volume":"34","author":[{"given":"Radha","family":"Devi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyush","family":"Dadwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshita","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2284_CR1","volume-title":"Bioactive cucurbitacins: therapeutic benefits, toxicity, and analysis","author":"J Ahamad","year":"2026","unstructured":"Ahamad J, Nollet LM (2026) Bioactive cucurbitacins: therapeutic benefits, toxicity, and analysis. CRC Press"},{"key":"2284_CR2","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/01480545.2020.1838538","volume":"45","author":"OS Aljohani","year":"2022","unstructured":"Aljohani OS (2022) Phytochemical evaluation of Cucumis prophetarum: protective effects against carrageenan-induced prostatitis in rats. Drug Chem Toxicol 45:1461\u20131469. https:\/\/doi.org\/10.1080\/01480545.2020.1838538","journal-title":"Drug Chem Toxicol"},{"key":"2284_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/2221-1691.377405","volume":"13","author":"A Arora","year":"2023","unstructured":"Arora A, Sharma N, Kakkar D (2023) Natural polysaccharides for ulcerative colitis: a general overview. Asian Pac J Trop Biomed 13:185\u2013194. https:\/\/doi.org\/10.4103\/2221-1691.377405","journal-title":"Asian Pac J Trop Biomed"},{"key":"2284_CR4","doi-asserted-by":"publisher","DOI":"10.2174\/1573401319666230816151001","author":"A Arora","year":"2024","unstructured":"Arora A, Sharma N, Sharma A (2024) Role of fruit-derived natural polysaccharide in ulcerative colitis. Curr Nutr Food Sci. https:\/\/doi.org\/10.2174\/1573401319666230816151001","journal-title":"Curr Nutr Food Sci"},{"key":"2284_CR5","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.2174\/1568026615666150427121331","volume":"15","author":"E Attard","year":"2015","unstructured":"Attard E, Martinoli M-G (2015) Cucurbitacin E, an experimental lead triterpenoid with anticancer, immunomodulatory and novel effects against degenerative diseases. A mini-review. Curr Top Med Chem 15:1708\u20131713","journal-title":"Curr Top Med Chem"},{"key":"2284_CR6","doi-asserted-by":"publisher","unstructured":"Bauleth M, Sheehama J, Cheikhyoussef N, Cheikhyoussef A, Makhaba M, Sharma R, Cupido C, Hussein AA, Cheikhyoussef A (2025) Phytochemicals from Cucumber (Cucumis sativus) By-products. Bioactive Phytochemicals in By-products from Bulb, Flower and Fruit Vegetables. Springer. https:\/\/doi.org\/10.1007\/978-3-031-77399-0_14","DOI":"10.1007\/978-3-031-77399-0_14"},{"key":"2284_CR7","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S536459","author":"S Bu","year":"2025","unstructured":"Bu S, Cheng X, Chen M, Yu Y (2025) Ulcerative colitis: advances in pathogenesis, biomarkers, and therapeutic strategies. Pharmacogenomics Pers Med. https:\/\/doi.org\/10.2147\/PGPM.S536459","journal-title":"Pharmacogenomics Pers Med"},{"key":"2284_CR8","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1007\/s10787-025-01898-5","volume":"33","author":"S Cao","year":"2025","unstructured":"Cao S, Wang Y, Tai Y, Han J, Zheng Y, Wang C, Zuo HX, Li MY, Xing Y, jin X (2025) Cucurbitacin B alleviates DSS-induced experimental colitis by targeting ZNF70 to suppress the NLRP3\/STAT3 signaling axis. Inflammopharmacology 33:5451\u20135469. https:\/\/doi.org\/10.1007\/s10787-025-01898-5","journal-title":"Inflammopharmacology"},{"key":"2284_CR9","doi-asserted-by":"publisher","DOI":"10.48130\/vegres-0024-0039","author":"Y Chai","year":"2024","unstructured":"Chai Y, Sun Y (2024) Advances in the biosynthesis, gene mining, and molecular mechanisms of cucurbitacin in Cucurbitaceae crops. Veg Res. https:\/\/doi.org\/10.48130\/vegres-0024-0039","journal-title":"Veg Res"},{"key":"2284_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1039\/B418841C","volume":"22","author":"JC Chen","year":"2005","unstructured":"Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX (2005) Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat Prod Rep 22:386\u2013399. https:\/\/doi.org\/10.1039\/B418841C","journal-title":"Nat Prod Rep"},{"key":"2284_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1248\/cpb.58.747","volume":"72","author":"C Chen","year":"2009","unstructured":"Chen C, Qiang S, Lou L, Zhao W (2009) Cucurbitane-type triterpenoids from the stems of Cucumis melo. J Nat Prod 72:824\u2013829. https:\/\/doi.org\/10.1248\/cpb.58.747","journal-title":"J Nat Prod"},{"key":"2284_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xplc.2024.100835ExternalLink","author":"G Chen","year":"2024","unstructured":"Chen G, Guo Z, Shu Y, Zhao Y, Qiu L, Duan S, Lin Y, He S, Li X, Feng X (2024) Biosynthetic pathway of prescription cucurbitacin IIa and high-level production of key triterpenoid intermediates in engineered yeast and tobacco. Plant Commun. https:\/\/doi.org\/10.1016\/j.xplc.2024.100835ExternalLink","journal-title":"Plant Commun"},{"key":"2284_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1744-7909.2007.00395.x","volume":"49","author":"AX Cheng","year":"2007","unstructured":"Cheng AX, Lou YG, Mao YB, Lu S, Wang LJ, Chen XY (2007) Plant terpenoids: biosynthesis and ecological functions. J Integr Plant Biol 49:179\u2013186. https:\/\/doi.org\/10.1111\/j.1744-7909.2007.00395.x","journal-title":"J Integr Plant Biol"},{"key":"2284_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106587","volume":"187","author":"S Dai","year":"2023","unstructured":"Dai S, Wang C, Zhao X, Ma C, Fu K, Liu Y, Peng C, Li Y (2023) Cucurbitacin B: a review of its pharmacology, toxicity, and pharmacokinetics. Pharmacol Res 187:106587. https:\/\/doi.org\/10.1016\/j.phrs.2022.106587","journal-title":"Pharmacol Res"},{"key":"2284_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111325","volume":"15","author":"EE Delgado-Tiburcio","year":"2022","unstructured":"Delgado-Tiburcio EE, Cadena-I\u00f1iguez J, Santiago-Osorio E, Ruiz-Posadas LDM, Castillo-Ju\u00e1rez I, Agui\u00f1iga-S\u00e1nchez I, Soto-Hern\u00e1ndez M (2022) Pharmacokinetics and biological activity of cucurbitacins. Pharmaceuticals Basel 15:1325. https:\/\/doi.org\/10.3390\/ph15111325","journal-title":"Pharmaceuticals Basel"},{"key":"2284_CR16","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.gtc.2020.07.005","volume":"49","author":"L Du","year":"2020","unstructured":"Du L, Ha C (2020) Epidemiology and pathogenesis of ulcerative colitis. Gastroenterol Clin North Am 49:643\u2013654. https:\/\/doi.org\/10.1016\/j.gtc.2020.07.005","journal-title":"Gastroenterol Clin North Am"},{"key":"2284_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1124\/jpet.106.107003","volume":"320","author":"JM Escandell","year":"2007","unstructured":"Escandell JM, Recio MC, M\u00e1\u00f1ez S, Giner RM, Cerd\u00e1-Nicol\u00e1s M, R\u00edos JL (2007) Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in Lewis rats by suppression of tumor necrosis factor-\u03b1 in T lymphocytes and macrophages. J Pharmacol Exp Ther 320:581\u2013590. https:\/\/doi.org\/10.1124\/jpet.106.107003","journal-title":"J Pharmacol Exp Ther"},{"key":"2284_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2025.106840","author":"W-B Feng","year":"2025","unstructured":"Feng W-B, Liu M-S, Zheng T-X, Lin Z-X, Xu H-W, Cai H-T, Zhang Y-B, Bai J-L, Yang M-X, Luo H (2025) New polyhydroxy cucurbitane-type triterpenoids from the tubers of Hemsleya chinensis and their cytotoxic activities. Fitoterapia. https:\/\/doi.org\/10.1016\/j.fitote.2025.106840","journal-title":"Fitoterapia"},{"key":"2284_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ijo.2017.4203","volume":"52","author":"S Garg","year":"2018","unstructured":"Garg S, Kaul SC, Wadhwa R (2018) Cucurbitacin B and cancer intervention: chemistry, biology and mechanisms. Int J Oncol 52:19\u201337. https:\/\/doi.org\/10.3892\/ijo.2017.4203","journal-title":"Int J Oncol"},{"key":"2284_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23123345","volume":"23","author":"W Ge","year":"2018","unstructured":"Ge W, Chen X, Han F, Liu Z, Wang T, Wang M, Chen Y, Ding Y, Zhang Q (2018) Synthesis of cucurbitacin B derivatives as potential anti-hepatocellular carcinoma agents. Molecules Basel 23:3345. https:\/\/doi.org\/10.3390\/molecules23123345","journal-title":"Molecules Basel"},{"key":"2284_CR21","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/B978-0-12-819483-6.00012-6","volume":"67","author":"S Ghosh","year":"2020","unstructured":"Ghosh S (2020) Triterpenoids: structural diversity, biosynthetic pathway, and bioactivity. Stud Nat Prod Chem 67:411\u2013461. https:\/\/doi.org\/10.1016\/B978-0-12-819483-6.00012-6","journal-title":"Stud Nat Prod Chem"},{"key":"2284_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sajb.2016.10.001","volume":"108","author":"S Hassan","year":"2017","unstructured":"Hassan S, Berchov\u00e1-B\u00edmov\u00e1 K, Petr\u00e1\u0161 J, Hassan K (2017) Cucurbitacin B interacts synergistically with antibiotics against Staphylococcus aureus clinical isolates and exhibits antiviral activity against HSV-1. S Afr J Bot 108:90\u201394. https:\/\/doi.org\/10.1016\/j.sajb.2016.10.001","journal-title":"S Afr J Bot"},{"key":"2284_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.22037\/ghfbb.v18i2.3105","volume":"18","author":"K Heydari","year":"2025","unstructured":"Heydari K, Rahnavard M, Ghahramani S, Hoseini A, Alizadeh-Navaei R, Rafati S, Raei M, Vahidipour M, Salehi F, Motafeghi F (2025) Global prevalence and incidence of inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Gastroenterol Hepatol Bed Bench 18:132. https:\/\/doi.org\/10.22037\/ghfbb.v18i2.3105","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"2284_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3109\/03639045.2012.702348","volume":"39","author":"H Hu","year":"2013","unstructured":"Hu H, Liu D, Zhao X, Qiao M, Chen D (2013) Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm 39:770\u2013779. https:\/\/doi.org\/10.3109\/03639045.2012.702348","journal-title":"Drug Dev Ind Pharm"},{"key":"2284_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2568-7","volume":"19","author":"N Hunsakunachai","year":"2019","unstructured":"Hunsakunachai N, Nuengchamnong N, Jiratchariyakul W, Kummalue T, Khemawoot P (2019) Pharmacokinetics of cucurbitacin B from Trichosanthes cucumerina L. in rats. BMC Complement Altern Med 19:157. https:\/\/doi.org\/10.1186\/s12906-019-2568-7","journal-title":"BMC Complement Altern Med"},{"key":"2284_CR77","doi-asserted-by":"publisher","unstructured":"Jafari E, Bahojb Mahdavi SZ, Azimi Hasani H, Memar MY, Pourbagherian O, Safaei S, Mokhtarzadeh AA, Dehghan G, Eskandani M (2026) \u03b1-pinene effects on the anticancer properties of Lactobacillus acidophilus probiotics against colorectal cancer cells. BMC Microbiol. https:\/\/doi.org\/10.1186\/s12866-025-04639-4","DOI":"10.1186\/s12866-025-04639-4"},{"key":"2284_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0304-3835(02)00497-4","volume":"189","author":"B Jayaprakasam","year":"2003","unstructured":"Jayaprakasam B, Seeram NP, Nair MG (2003) Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett 189:11\u201316. https:\/\/doi.org\/10.1016\/S0304-3835(02)00497-4","journal-title":"Cancer Lett"},{"key":"2284_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ympev.2017.03.002","volume":"111","author":"HR Kates","year":"2017","unstructured":"Kates HR, Soltis PS, Soltis DE (2017) Evolutionary and domestication history of Cucurbita (pumpkin and squash) species inferred from 44 nuclear loci. Mol Phylogenet Evol 111:98\u2013109. https:\/\/doi.org\/10.1016\/j.ympev.2017.03.002","journal-title":"Mol Phylogenet Evol"},{"key":"2284_CR28","doi-asserted-by":"publisher","unstructured":"Kates HR (2019) Pumpkins, squashes, and gourds (Cucurbita L.) of North America. North American crop wild relatives, volume 2: important species. Springer. https:\/\/doi.org\/10.1007\/978-3-319-97121-6_6","DOI":"10.1007\/978-3-319-97121-6_6"},{"key":"2284_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/0973-7847.156314","volume":"9","author":"U Kaushik","year":"2015","unstructured":"Kaushik U, Aeri V, Mir SR (2015) Cucurbitacins\u2013an insight into medicinal leads from nature. Pharmacogn Rev 9:12. https:\/\/doi.org\/10.4103\/0973-7847.156314","journal-title":"Pharmacogn Rev"},{"key":"2284_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12272-014-0386-5","volume":"38","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Kim J-K (2015) Antiangiogenic effects of cucurbitacin-I. Arch Pharm Res 38:290\u2013298. https:\/\/doi.org\/10.1007\/s12272-014-0386-5","journal-title":"Arch Pharm Res"},{"key":"2284_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/08923973.2015.1085065","volume":"37","author":"M Kim","year":"2015","unstructured":"Kim M, Park SY, Jin ML, Park G, Son H-J (2015) Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages. Immunopharmacol Immunotoxicol 37:473\u2013480. https:\/\/doi.org\/10.3109\/08923973.2015.1085065","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2284_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13580-018-0066-3","volume":"59","author":"Y-C Kim","year":"2018","unstructured":"Kim Y-C, Choi D, Zhang C, Liu H-F, Lee S (2018) Profiling cucurbitacins from diverse watermelons (Citrullus spp.). Hortic Environ Biotechnol 59:557\u2013566. https:\/\/doi.org\/10.1007\/s13580-018-0066-3","journal-title":"Hortic Environ Biotechnol"},{"key":"2284_CR33","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.bmc.2012.03.001","volume":"20","author":"KL Lang","year":"2012","unstructured":"Lang KL, Silva IT, Zimmermann LA, Machado VR, Teixeira MR, Lapuh MI, Galetti MA, Palermo JA, Cabrera GM, Bernardes LSC (2012) Synthesis and cytotoxic activity evaluation of dihydrocucurbitacin B and cucurbitacin B derivatives. Bioorg Med Chem 20:3016\u20133030. https:\/\/doi.org\/10.1016\/j.bmc.2012.03.001","journal-title":"Bioorg Med Chem"},{"key":"2284_CR34","doi-asserted-by":"crossref","unstructured":"Lebeda A, Widrlechner M, Staub J, Ezura H, Zalapa J, Kr\u00edstkov\u00e1 H (2006) Cucurbits (Cucurbitaceae; Cucumis spp., Cucurbita spp., Citrullus spp.). Genetic resources, chromosome engineering, and crop improvement. Taylor & Francis Publishing, Boca, FL","DOI":"10.1201\/9781420009569.ch8"},{"key":"2284_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.phytol.2016.08.011","volume":"18","author":"Y-D Li","year":"2016","unstructured":"Li Y-D, Yi S-R, Sun X-B, Zhou X-Y, Zhang H-Y, Wang Y-Q, Yang J-S, Xu X-D, Ma G-X (2016) Bioactive cucurbitane triterpenoids from the tubers of Hemsleya penxianensis. Phytochem Lett 18:5\u20139. https:\/\/doi.org\/10.1016\/j.phytol.2016.08.011","journal-title":"Phytochem Lett"},{"key":"2284_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.fitote.2017.06.009","volume":"120","author":"P Li","year":"2017","unstructured":"Li P, Zhu N, Hu M, Wu H, Yu T, Wu T, Zhang D, Sun Z, Yang J, Ma G (2017) New cucurbitane triterpenoids with cytotoxic activities from Hemsleya penxianensis. Fitoterapia 120:158\u2013163. https:\/\/doi.org\/10.1016\/j.fitote.2017.06.009","journal-title":"Fitoterapia"},{"key":"2284_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115707","volume":"168","author":"Y Li","year":"2023","unstructured":"Li Y, Li Y, Yao Y, Li H, Gao C, Sun C, zhuang J (2023) Potential of cucurbitacin as an anticancer drug. Biomed Pharmacother 168:115707. https:\/\/doi.org\/10.1016\/j.biopha.2023.115707","journal-title":"Biomed Pharmacother"},{"key":"2284_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-025-01922-5","volume":"15","author":"J Li","year":"2025","unstructured":"Li J, Shen X, Wu X, Zhao F, Tang W, Wu M, Hu F, Hu X, Wang F, Zhang Q (2025) Cucurbitacin B alleviates DSS-induced ulcerative colitis by improving gut microbiota disorder in C57BL\/6 mice. AMB Express 15:111. https:\/\/doi.org\/10.1186\/s13568-025-01922-5","journal-title":"AMB Express"},{"key":"2284_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2023.105441","volume":"166","author":"F Lian","year":"2023","unstructured":"Lian F, Chi J, Meng Q, Li Q, Chen A, Wang Z, Dai L (2023) Cucurbitane triterpenes from Hemsleya chinensis tubers and their anti-inflammatory activities. Fitoterapia 166:105441. https:\/\/doi.org\/10.1016\/j.fitote.2023.105441","journal-title":"Fitoterapia"},{"key":"2284_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","volume":"5","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C (2024) Ulcerative colitis: molecular insights and intervention therapy. Mol Biomed 5:42. https:\/\/doi.org\/10.1186\/s43556-024-00207-w","journal-title":"Mol Biomed"},{"key":"2284_CR41","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2702071","volume":"27","author":"Z Liu","year":"2022","unstructured":"Liu Z, Kumar M, Kabra A (2022) Cucurbitacin B exerts neuroprotection in a murine Alzheimer\u2019s disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. Front Biosci Landmark Ed 27:71. https:\/\/doi.org\/10.31083\/j.fbl2702071","journal-title":"Front Biosci Landmark Ed"},{"key":"2284_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jare.2024.05.021","volume":"71","author":"J Lu","year":"2025","unstructured":"Lu J, Yan S, Xue Z (2025) Biosynthesis and functions of triterpenoids in cereals. J Adv Res 71:155\u2013171. https:\/\/doi.org\/10.1016\/j.jare.2024.05.021","journal-title":"J Adv Res"},{"key":"2284_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.sajb.2021.08.044","volume":"145","author":"D Maja","year":"2022","unstructured":"Maja D, Mavengahama S, Mashilo J (2022) Cucurbitacin biosynthesis in cucurbit crops, their pharmaceutical value and agricultural application for management of biotic and abiotic stress: a review. S Afr J Bot 145:3\u201312. https:\/\/doi.org\/10.1016\/j.sajb.2021.08.044","journal-title":"S Afr J Bot"},{"key":"2284_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-39173-7_2","volume-title":"Biology of composts","author":"PW Mashela","year":"2020","unstructured":"Mashela PW, Pofu KM, Shokoohi E (2020) Biological sterilisation, detoxification and stimulation of Cucurbitacin-containing manure. Biology of composts. Springer. https:\/\/doi.org\/10.1007\/978-3-030-39173-7_2"},{"key":"2284_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29174193","volume":"29","author":"W Nie","year":"2024","unstructured":"Nie W, Wang Y, Tian X, Liu J, Jin Z, Xu J, He M, Shen Q, Guo H, Luan T (2024) Cucurbitacin B and its derivatives: a review of progress in biological activities. Molecules 29:4193. https:\/\/doi.org\/10.3390\/molecules29174193","journal-title":"Molecules"},{"key":"2284_CR46","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/1744666X.2017.1343668","volume":"13","author":"J Pan\u00e9s","year":"2017","unstructured":"Pan\u00e9s J, Alfaro I (2017) New treatment strategies for ulcerative colitis. Expert Rev Clin Immunol 13:963\u2013973. https:\/\/doi.org\/10.1080\/1744666X.2017.1343668","journal-title":"Expert Rev Clin Immunol"},{"key":"2284_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/7397_2016_3","volume-title":"Genetics and genomics of Cucurbitaceae","author":"HS Paris","year":"2016","unstructured":"Paris HS (2016) Genetic resources of pumpkins and squash, Cucurbita spp. Genetics and genomics of Cucurbitaceae. Springer. https:\/\/doi.org\/10.1007\/7397_2016_3"},{"key":"2284_CR48","doi-asserted-by":"publisher","DOI":"10.2174\/0115734072316509240530044415","volume":"21","author":"R Paul","year":"2025","unstructured":"Paul R, Nag S, Mondal S, Panigrahi N, Roy P, Sahoo SK, Sundararajan R, Mohiuddin A (2025) Cucurbitacin: unveiling its role as phytomolecule in health benefits. Curr Bioact Compd 21:e070624230855. https:\/\/doi.org\/10.2174\/0115734072316509240530044415","journal-title":"Curr Bioact Compd"},{"key":"2284_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00011-013-0598-z","volume":"62","author":"J Qiao","year":"2013","unstructured":"Qiao J, Xu L-H, He J, Ouyang D-Y, He X-H (2013) Cucurbitacin E exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-\u03baB nuclear translocation. Inflamm Res 62:461\u2013469. https:\/\/doi.org\/10.1007\/s00011-013-0598-z","journal-title":"Inflamm Res"},{"key":"2284_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2022.113123","volume":"197","author":"Z Qing","year":"2022","unstructured":"Qing Z, Shi Y, Han L, Li P, Zha Z, Liu C, Liu X, Huang P, Liu Y, Tang Q (2022) Identification of seven undescribed cucurbitacins in Cucumis sativus (cucumber) and their cytotoxic activity. Phytochemistry 197:113123. https:\/\/doi.org\/10.1016\/j.phytochem.2022.113123","journal-title":"Phytochemistry"},{"key":"2284_CR76","doi-asserted-by":"crossref","unstructured":"Ramezani M, Hasani M, Ramezani F, Abdolmaleki MK (2020) Cucurbitacins: a focus on Cucurbitacin E as a natural product and their biological activities. Pharm Sci 27:1\u201313","DOI":"10.34172\/PS.2020.66"},{"key":"2284_CR51","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/ptr.8454","volume":"39","author":"M Sahu","year":"2025","unstructured":"Sahu M, Paliwal T, Jain S, Verma K, Chakraborty D, Jaiswal S, Dwivedi J, Sharma S (2025) Multifaceted therapeutic impacts of Cucurbitacin B: recent evidences from preclinical studies. Phytother Res 39:1966\u20131995. https:\/\/doi.org\/10.1002\/ptr.8454","journal-title":"Phytother Res"},{"key":"2284_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpls.2011.00025","volume":"2","author":"S Sawai","year":"2011","unstructured":"Sawai S, Saito K (2011) Triterpenoid biosynthesis and engineering in plants. Front Plant Sci 2:25. https:\/\/doi.org\/10.3389\/fpls.2011.00025","journal-title":"Front Plant Sci"},{"key":"2284_CR53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","volume":"21","author":"JP Segal","year":"2021","unstructured":"Segal JP, Leblanc J-F, Hart AL (2021) Ulcerative colitis: an update. Clin Med Lond 21:135\u2013139. https:\/\/doi.org\/10.7861\/clinmed.2021-0080","journal-title":"Clin Med Lond"},{"key":"2284_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.fct.2013.11.040","volume":"64","author":"C-R Seo","year":"2014","unstructured":"Seo C-R, Yang DK, Song N-J, Yun UJ, Gwon A-R, Jo D-G, Cho JY, Yoon K, Ahn J-Y, Nho CW (2014) Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. Food Chem Toxicol 64:217\u2013224. https:\/\/doi.org\/10.1016\/j.fct.2013.11.040","journal-title":"Food Chem Toxicol"},{"key":"2284_CR78","doi-asserted-by":"publisher","unstructured":"Sergazy S, Aliakpar S, Adekenova G, Itzhanova K, Taglialatela-Scafati O, Adekenov S (2026) Terpenoid phytosomes as advanced delivery systems: molecular interactions, pharmacological potential, and scalable manufacturing approaches. Int J Mol Sci 27:2868. https:\/\/doi.org\/10.3390\/ijms27062868","DOI":"10.3390\/ijms27062868"},{"key":"2284_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138321","volume":"1312","author":"R Sharma","year":"2024","unstructured":"Sharma R, Thakur S, Kumar M, Vamsi K, Jachak S, Singh IP, Kumar R (2024) Synthetic modifications of therapeutically relevant pre-assembled cucurbitacins: synthetic strategies and structure-activity relationships. J Mol Struct 1312:138321. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138321","journal-title":"J Mol Struct"},{"key":"2284_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1875-5364(20)30058-3","volume":"18","author":"J Si-Yuan","year":"2020","unstructured":"Si-Yuan J, Zi-Dan W, Zheng-Yi W (2020) In vitro antitumor effect of cucurbitacin E on human lung cancer cell line and its molecular mechanism. Chin J Nat Med 18:483\u2013490. https:\/\/doi.org\/10.1016\/S1875-5364(20)30058-3","journal-title":"Chin J Nat Med"},{"key":"2284_CR57","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/sj.onc.1208470","volume":"24","author":"J Sun","year":"2005","unstructured":"Sun J, Blaskovich MA, Jove R, Livingston SK, Coppola D, Sebti SM (2005) Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 24:3236\u20133245. https:\/\/doi.org\/10.1038\/sj.onc.1208470","journal-title":"Oncogene"},{"key":"2284_CR79","doi-asserted-by":"publisher","unstructured":"Taghipour YD, Bahramsoltani R, Marques AM, Naseri R, Rahimi R, Haratipour P, Panah AI, Farzaei MH, Abdollahi M (2018) A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets. DARU J Pharm Sci 26:229\u2013239. https:\/\/doi.org\/10.1007\/s40199-018-0222-4","DOI":"10.1007\/s40199-018-0222-4"},{"key":"2284_CR58","doi-asserted-by":"publisher","first-page":"18662","DOI":"10.1074\/jbc.RA119.009944","volume":"294","author":"S Takase","year":"2019","unstructured":"Takase S, Kera K, Nagashima Y, Mannen K, Hosouchi T, Shinpo S, Kawashima M, Kotake Y, Yamada H, Saga Y (2019) Allylic hydroxylation of triterpenoids by a plant cytochrome P450 triggers key chemical transformations that produce a variety of bitter compounds. J Biol Chem 294:18662\u201318673. https:\/\/doi.org\/10.1074\/jbc.RA119.009944","journal-title":"J Biol Chem"},{"key":"2284_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/jbcpp-2018-0036","volume":"30","author":"N Tatiya-Aphiradee","year":"2018","unstructured":"Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K (2018) Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol 30:1\u201310. https:\/\/doi.org\/10.1515\/jbcpp-2018-0036","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"10","key":"2284_CR60","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.2174\/1871520620666200415101701","volume":"20","author":"H Torres-Moreno","year":"2020","unstructured":"Torres-Moreno H, Marcotullio MC, Velazquez C, Arenas-Luna VM, Hern\u00e1ndez-Guti\u00e9rrez S, Robles-Zepeda RE (2020a) Cucurbitacin IIb from Ibervillea sonorae induces apoptosis and cell cycle arrest via STAT3 inhibition. Anti-Cancer Agents Med Chem 20(10):1188\u20131196","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"2284_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04771-7","volume":"157","author":"H Torres-Moreno","year":"2020","unstructured":"Torres-Moreno H, Marcotullio MC, Velazquez C, Ianni F, Garibay-Escobar A, Robles-Zepeda RE (2020b) Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cells. Steroids 157:108597. https:\/\/doi.org\/10.1186\/s12967-023-04771-7","journal-title":"Steroids"},{"key":"2284_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40643-019-0242-z","volume":"6","author":"Q Wang","year":"2019","unstructured":"Wang Q, Quan S, Xiao H (2019) Towards efficient terpenoid biosynthesis: manipulating IPP and DMAPP supply. Bioresour Bioprocess 6:1\u201313. https:\/\/doi.org\/10.1186\/s40643-019-0242-z","journal-title":"Bioresour Bioprocess"},{"key":"2284_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04771-7","volume":"21","author":"L Wang","year":"2023","unstructured":"Wang L, Xu H, Li X, Chen H, Zhang H, Zhu X, Lin Z, Guo S, Bao Z, Rui H (2023) Cucurbitacin E reduces IL-1\u03b2-induced inflammation and cartilage degeneration by inhibiting the PI3K\/Akt pathway in osteoarthritic chondrocytes. J Transl Med 21:880. https:\/\/doi.org\/10.1186\/s12967-023-04771-7","journal-title":"J Transl Med"},{"key":"2284_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01287","volume":"10","author":"D Wu","year":"2019","unstructured":"Wu D, Wang Z, Lin M, Shang Y, Wang F, Zhou J, Wang F, Zhang X, Luo X, Huang W (2019) In vitro and in vivo antitumor activity of cucurbitacin C, a novel natural product from cucumber. Front Pharmacol 10:1287. https:\/\/doi.org\/10.3389\/fphar.2019.01287","journal-title":"Front Pharmacol"},{"key":"2284_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2022.100088","volume":"8","author":"Q Wu","year":"2022","unstructured":"Wu Q, Huang Z, Xiao Y, Chang J, Liu P, Liu C, Liu X (2022) Preparation, characterization and pharmacokinetics of Cucurbitacin B solid dispersion. OpenNano 8:100088. https:\/\/doi.org\/10.1016\/j.onano.2022.100088","journal-title":"OpenNano"},{"key":"2284_CR66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5152\/tjg.2024.24449","volume":"36","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yang Q (2024) Cucurbitacin IIa ameliorates DSS-induced ulcerative colitis via enhancing intestinal barrier function and inhibiting PERK\/ATF4\/CHOP signaling pathway. Turk J Gastroenterol 36:229. https:\/\/doi.org\/10.5152\/tjg.2024.24449","journal-title":"Turk J Gastroenterol"},{"key":"2284_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26168003","volume":"26","author":"D Yin","year":"2025","unstructured":"Yin D, Chen H, Lin S, Sun Y, Jing X, Chang R, Feng Y, Dong X, Qu C, Ni J (2025) Recent advances in the application of Cucurbitacin B as an anticancer agent. Int J Mol Sci 26:8003. https:\/\/doi.org\/10.3390\/ijms26168003","journal-title":"Int J Mol Sci"},{"key":"2284_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10713-8","author":"Z Yu","year":"2023","unstructured":"Yu Z, Liang S, Ji L, Cheng Y, Yan W, Gao R, Zhang F (2023) Network pharmacological analysis and experimental study of cucurbitacin B in oral squamous cell carcinoma. Mol Divers. https:\/\/doi.org\/10.1007\/s11030-023-10713-8","journal-title":"Mol Divers"},{"key":"2284_CR69","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1002\/ptr.7077","volume":"35","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Wang J, Huang Q, Ren Y, Li T, Zhang X, Yao R, Sun J (2021) Cucurbitacin II a: a review of phytochemistry and pharmacology. Phytother Res 35:4155\u20134170. https:\/\/doi.org\/10.1002\/ptr.7077","journal-title":"Phytother Res"},{"key":"2284_CR70","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S456353","author":"F Zhan","year":"2024","unstructured":"Zhan F, Song W, Fan Y, Wang F, Wang Q (2024) Cucurbitacin E alleviates colonic barrier function impairment and inflammation response and improves microbial composition on experimental colitis models. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S456353","journal-title":"J Inflamm Res"},{"key":"2284_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0168-9452(02)00425-9","volume":"164","author":"D Zhang","year":"2003","unstructured":"Zhang D, Halaweish FT (2003) Isolation and identification of foetidissimin: a novel ribosome-inactivating protein from Cucurbita foetidissima. Plant Sci 164:387\u2013393. https:\/\/doi.org\/10.1016\/S0168-9452(02)00425-9","journal-title":"Plant Sci"},{"key":"2284_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38051","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Guo K, Yan Y, Jiang B (2024) Cucurbitacin IIb alleviates colitis via regulating gut microbial composition and metabolites. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38051","journal-title":"Heliyon"},{"key":"2284_CR73","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S500722","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Jiang B, Zuo S (2025) Cucurbitacin IIa alleviates colitis via promoting the release of host-derived extracellular vesicles encapsulating microRNA-30b-5p. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S500722","journal-title":"J Inflamm Res"},{"key":"2284_CR74","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/cjoc.202200106","volume":"40","author":"N Zhuo","year":"2022","unstructured":"Zhuo N, Ma J, Cao L, Chen L, Nan F (2022) Protecting-group-free one-step palladium-catalyzed coupling on C25 of Cucurbitacin B expands chemical diversity with improved cytotoxicity against A549 cells. Chin J Chem 40:1662\u20131666. https:\/\/doi.org\/10.1002\/cjoc.202200106","journal-title":"Chin J Chem"},{"key":"2284_CR75","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/metabo13101081","volume":"13","author":"B Zieniuk","year":"2023","unstructured":"Zieniuk B, Pawe\u0142kowicz M (2023) Recent advances in the application of cucurbitacins as anticancer agents. Metabolites Basel 13:1081. https:\/\/doi.org\/10.3390\/metabo13101081","journal-title":"Metabolites Basel"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02284-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02284-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:16:08Z","timestamp":1784704568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02284-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2284"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02284-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the author(s) used Quillbot for enhancing the readability, Grammarly for checking grammar and spellings and Endnote for referencing. After using this tool, the author (s) reviewed and edited the content as needed and takes full responsibility for the content of the published article.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}]}}